Accelerating Oncology Biomarker Interpretation from NGS Panels with CGW Plus

How does your laboratory determine which oncology variants merit reporting and how to tier and interpret them in the clinical report? And how do you maintain consistency across cases, while incorporating new evidence as it becomes available? These challenges demand technology solutions that help your staff focus their medical and scientific judgment where it’s needed most.
In this session, we’ll showcase how Velsera’s CGW Plus solves these challenges with:

A reimagined interface for variant quality assessment to focus your attention on borderline calls.

Robust workflows for rapid VUS triage, leveraging oncogenicity data and our industry-leading curated oncology Knowledgebase, for consistent application of your lab’s variant review SOPs.

Adaptive learning capabilities that remember your past reporting decisions and interpretations and highlight newly available evidence.